Axsome Therapeutics, Inc.
AXSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001579428
In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Axsome Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 219
- +35 vs. Q3 2022
- Shares held
- 30.1M
- +4.52M (+17.7%) vs. Q3 2022
- Total value
- $2.32B
- +$1.18B (+103.4%) vs. Q3 2022
- New holders
- 62
- 56 more added
- Sold out
- 27
- 75 more reduced
4 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXSM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 505 | $9.34B |
| Q1 2026 | 410 | $6.41B |
| Q4 2025 | 399 | $6.86B |
| Q3 2025 | 355 | $4.51B |
| Q2 2025 | 348 | $3.95B |
| Q1 2025 | 353 | $4.37B |
| Q4 2024 | 292 | $3.15B |
| Q3 2024 | 280 | $3.48B |
| Q2 2024 | 257 | $3.28B |
| Q1 2024 | 259 | $3.09B |
| Q4 2023 | 245 | $3.07B |
| Q3 2023 | 227 | $2.65B |
| Q2 2023 | 231 | $2.61B |
| Q1 2023 | 197 | $1.97B |
| Q4 2022 | 219 | $2.32B |
| Q3 2022 | 188 | $1.15B |
| Q2 2022 | 174 | $826.7M |
| Q1 2022 | 175 | $787.4M |
| Q4 2021 | 167 | $704.2M |
| Q3 2021 | 171 | $627.3M |
| Q2 2021 | 176 | $1.51B |
| Q1 2021 | 184 | $1.31B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Axsome Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cannell Peter B & Co Inc | 370,020 | $28.5M | 1.03% | +320,680+649.9% | Added |
| Boxer Capital, LLC | 400,000 | $30.9M | 1.66% | +400,000 | New |
| Bellevue Group AG | 436,658 | $33.7M | 0.45% | −59,866−12.1% | Reduced |
| Hood River Capital Management LLC | 460,295 | $35.5M | 1.29% | +460,295 | New |
| Morgan Stanley | 477,256 | $36.8M | 0.00% | −122,275−20.4% | Reduced |
| Geode Capital Management, LLC | 624,589 | $48.2M | 0.01% | +62,000+11.0% | Added |
| Point72 Asset Management, L.P. | 650,065 | $50.1M | 0.19% | +32,165+5.2% | Added |
| Avidity Partners Management LP | 670,000 | $51.7M | 1.21% | −868,600−56.5% | Reduced |
| VR Adviser, LLC | 670,718 | $51.7M | 8.71% | +670,718 | New |
| FMR LLC | 734,437 | $56.6M | 0.01% | +385,541+110.5% | Added |
| State Street Corp | 756,870 | $58.4M | 0.00% | +45,538+6.4% | Added |
| Alethea Capital Management, LLC | 785,683 | $60.6M | 58.09% | −2,580−0.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,065,000 | $82.1M | 0.20% | +915,000+610.0% | Added |
| PFM Health Sciences, LP | 1,092,831 | $84.3M | 3.56% | −566,902−34.2% | Reduced |
| BVF Inc | 1,755,000 | $135.4M | 5.71% | +1,755,000 | New |
| Fairmount Funds Management LLC | 2,011,647 | $155.2M | 24.61% | +115,000+6.1% | Added |
| BlackRock Inc. | 2,502,977 | $193.1M | 0.01% | +310,722+14.2% | Added |
| RTW Investments, LP | 2,980,482 | $229.9M | 4.69% | +1,098,318+58.4% | Added |
| Vanguard Group Inc | 3,417,628 | $263.6M | 0.01% | +306,128+9.8% | Added |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −520,080−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −351,140−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −141,312−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −35,009−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −26,572−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −20,580−100.0% | Sold out |
| International Biotechnology Trust PLC | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −10,943−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −10,916−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −9,565−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −9,466−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −8,397−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −6,812−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −6,268−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −6,040−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −5,444−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −4,834−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −4,602−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −4,505−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −3,053−100.0% | Sold out |
| Columbia Asset Management | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −214−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −225−100.0% | Sold out |
| Carmichael Hill & Associates, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Morgan Jess S & Co Inc | – | – | – | – | Not filed |
| ACT Capital Management, LLC | – | – | – | – | Not filed |
| American Portfolios Advisors | – | – | – | – | Not filed |
| Siena Capital LLC | – | – | – | – | Not filed |